UNSPSC 51291802: Eclanamine

This classification denotes an antidepressant agent with the molecular formula C16H22CL2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 5Y67H9W4KQ chemically known as propanamide, n-(3,4-dichlorophenyl)-n-(2-(dimethylamino)cyclopentyl)-, trans-(+/-)- but generally known as eclanamine, which bears US NIH Compound Identifier 130380. European Medicines Agency schedules Eclanamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06447MIG.

UNSPSC 51291802 Eclanamine is a Commodity code under which state and local governments procure naloxone and related drug-response products for community health and emergency-response programs. The code captures pharmaceutical and medical-supply procurement tied to opioid-crisis mitigation and harm-reduction initiatives. Issuing bodies include county health departments and public health authorities that operate or fund community health programs and emergency medical services.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023. The contract carries an initial two-year term with a one-year renewal option and requires vendors to submit unit costs, maintain workers' compensation and general liability insurance, comply with E-Verify, and deliver all products with shipping costs included in the bid price. The procurement may be funded through FEMA and subjects winning vendors to federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. A three-month probationary period allows the county to terminate with or without cause. No explicit set-aside designations are stated in the opportunity record.